Interplay between α-, β-, and γ-Secretases Determines Biphasic Amyloid-β Protein Level in the Presence of a γ-Secretase Inhibitor

This publication has 41 references indexed in Scilit:

• Quantitative Pharmacokinetic/Pharmacodynamic Analyses Suggest That the 129/SVE Mouse Is a Suitable Preclinical Pharmacology Model for Identifying Small-Molecule γ-Secretase Inhibitors
  The Journal of Pharmacology and Experimental Therapeutics, 2011
• BACE-1 inhibition prevents the γ-secretase inhibitor evoked Aβ rise in human neuroblastoma SH-SY5Y cells
  Journal of Biomedical Science, 2011
• Inhibitors of γ‐secretase stabilize the complex and differentially affect processing of amyloid precursor protein and other substrates
  The FASEB Journal, 2011
• ADAM10 is the physiologically relevant, constitutive α‐secretase of the amyloid precursor protein in primary neurons
  The EMBO Journal, 2010
• Acute γ-Secretase Inhibition of Nonhuman Primate CNS Shifts Amyloid Precursor Protein (APP) Metabolism from Amyloid-β Production to Alternative APP Fragments without Amyloid-β Rebound
  Journal of Neuroscience, 2010
• Allosteric Modulation of PS1/γ-Secretase Conformation Correlates with Amyloid β42/40 Ratio
  PLOS ONE, 2009
• Alternative pathways for production of β-amyloid peptides of Alzheimer's disease
  Biological Chemistry, 2008
• Direct and Potent Regulation of γ-Secretase by Its Lipid Microenvironment
  Journal of Biological Chemistry, 2008
• Human amyloid-β synthesis and clearance rates as measured in cerebrospinal fluid in vivo
  Nature Medicine, 2006
• Putative function of ADAM9, ADAM10, and ADAM17 as APP -secretase
  Biochemical and Biophysical Research Communications, 2003